Carsten Boess is Director of Avidity Biosciences, Inc.. Currently has a direct ownership of 6,692 shares of RNA, which is worth approximately $238,168. The most recent transaction as insider was on Jun 10, 2025, when has been sold 6,692 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.69K
n/a 3M change
n/a 12M change
Total Value Held $238,168

CARSTEN BOESS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2025
BUY
Grant, award, or other acquisition
-
6,692 Added 50.0%
6,692 Common Stock

Also insider at

RCKT
ROCKET PHARMACEUTICALS, INC. Healthcare
CB

Carsten Boess

Director
Cranbury, NJ

Track Institutional and Insider Activities on RNA

Follow Avidity Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNA shares.

Notify only if

Insider Trading

Get notified when an Avidity Biosciences, Inc. insider buys or sells RNA shares.

Notify only if

News

Receive news related to Avidity Biosciences, Inc.

Track Activities on RNA